首页> 外国专利> Aminophenyl piperidines and piperazines have farnesyl protein transferase and geranyl geranyl protein transferase inhibiting activity for treatment of cancers and other disorders

Aminophenyl piperidines and piperazines have farnesyl protein transferase and geranyl geranyl protein transferase inhibiting activity for treatment of cancers and other disorders

机译:氨基苯基哌啶和哌嗪具有抑制法呢基蛋白转移酶和香叶基香叶基香叶基蛋白转移酶的活性,可用于治疗癌症和其他疾病

摘要

Aminophenyl piperidine and piperazine derivatives (I), their salts, solvates, optical isomers and mixtures. Aminophenyl piperidine and piperazine derivatives (I), their salts, solvates, optical isomers and mixtures W' = H, COR6, CSR6, SO2R6, CO(CH2)nR6, or (CH2)nR7; X' = CH or N; Y' = (CH2)n, CO, CH2CO, CH=CH-CO, or CH2CH2CO, such that when it is not (CH2)n, W = H; Z = a heterocycle as defined below; R1 = H, 1-6C alkyl, halo, OCH3, or CF3; R2 and R3 = H or 1-6C alkyl; R4 = H, 1-6C alkyl (optionally substituted by aryl, cyanophenyl, nitrophenyl, aminophenyl, methoxyphenyl, hydroxyphenyl, heterocyclyl, halo, CN, NO2, OR2, SR2, NR2R3, COOR2), aryl or heterocyclyl; R5 = H, COR7, SO2R7, (CH2)nR7, CO(CH2)nR7, CO(CH2)nOR7, (CH2)nCSNR7R8, (CH2)mNHCOR7, (CH2)mNHCONR7R8, or (CH2)mNHCSR7R8; R6 = phenyl or naphthyl (optionally substituted by 1-6C alkyl, halo, phenyl, naphthyl, CN, NO2, CF3, OR7, SR7, NR7R8, COOR7, CONR7R8, or COR7), 1-6C alkyl, cycloalkyl, heterocycle, or NR7R8; R7 and R8 = H, 1-15C alkyl (optionally substituted by halo, COOCH3, COOH, OCH3, OH, CF3, CN, SCH3), cycloalkyl (optionally substituted by halo, OCH3, OH, CF3, CN, or SCH3), alkyl cycloalkyl ((optionally substituted by halo, OCH3, OH, CF3, CN, or SCH3), heterocycle, alkyl heterocycle, aryl or alkaryl, or R7 and R8 when they are adjacent may be taken together with the N to form a 4 - 6 membered ring; n = 0 - 10; and m = 2 - 10. Independent claims are also included for: (1) preparation of (I) by condensation of (V); and (2) preparation of (I) by condensation of (VIII). R'4 = a precursor of R4; and P1 = a protecting group.
机译:氨基苯基哌啶和哌嗪衍生物(I),其盐,溶剂化物,旋光异构体和混合物。氨基苯基哌啶和哌嗪衍生物(I),它们的盐,溶剂化物,旋光异构体和混合物W′= H,COR6,CSR6,SO2R6,CO(CH2)nR6或(CH2)nR7; X'= CH或N; Y’=(CH 2)n,CO,CH 2 CO,CH = CH-CO或CH 2 CH 2 CO,使得当不是(CH 2)n时,W = H; Z =定义如下的杂环; R1 = H,1-6C烷基,卤素,OCH3或CF3; R2和R3 = H或1-6C烷基; R4 = H,1-6C烷基(任选地被芳基,氰基苯基,硝基苯基,氨基苯基,甲氧基苯基,羟苯基,杂环基,卤素,CN,NO2,OR2,SR2,NR2R3,COOR2取代),芳基或杂环基; R5 = H,COR7,SO2R7,(CH2)nR7,CO(CH2)nR7,CO(CH2)nOR7,(CH2)nCSNR7R8,(CH2)mNHCOR7,(CH2)mNHCONR7R8或(CH2)mNHCSR7R8; R6 =苯基或萘基(可选地被1-6C烷基,卤素,苯基,萘基,CN,NO2,CF3,OR7,SR7,NR7R8,COOR7,CONR7R8或COR7取代),1-6C烷基,环烷基,杂环或NR7R8; R7和R8 = H,1-15C烷基(可选被卤素,COOCH3,COOH,OCH3,OH,CF3,CN,SCH3取代),环烷基(可选被卤素,OCH3,OH,CF3,CN或SCH3取代),烷基环烷基((可选被卤素,OCH3,OH,CF3,CN或SCH3取代),杂环,烷基杂环,芳基或烷芳基;或当相邻时的R7和R8可以与N一起形成4- 6元环; n = 0-10; m = 2-10。还包括以下方面的独立权利要求:(1)通过缩合(V)制备(I);和(2)通过缩合制备(I) R′4 = R4的前体; P1 =保护基。

著录项

  • 公开/公告号FR2815032A1

    专利类型

  • 公开/公告日2002-04-12

    原文格式PDF

  • 申请/专利权人 PIERRE FABRE MEDICAMENT;

    申请/专利号FR20000012919

  • 申请日2000-10-10

  • 分类号C07D233/64;C07D409/12;C07D409/14;C07D401/12;A61K31/496;A61K31/4523;A61P35/00;A61P9/10;

  • 国家 FR

  • 入库时间 2022-08-22 00:24:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号